Patent · US Active

6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof

US8846676B2 · kind B2 · utility

1Cited by

2References

19Claims

0Family size

Assignee

Sanofi · FR

Inventors

Antonio Almario Garcia · Paris, FR
Mathieu Barrague · Bound Brook, US
Philippe Burnier · Maisons-Laffitte, FR
Cecile Enguehard-Gueiffier · Tours, FR
Zhongli Gao · Flemington, US
Pascal George · Rambouillet, FR
Alain Gueiffier · Tours, FR
Adrien Tak Li · Fontenay-aux-Roses, FR
Frederic Peuch · Gif-sur-Yvette, FR
Roy Vaz · Readington, US
Qiuxia Zhao · Green Brook, US

Key dates

Filing date	Sep 14, 2012
Grant date	Sep 30, 2014
Priority date	—
Expiry date	Sep 14, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the 6-cycloamino-3-(pyridin-4-yl)imidazo[I,2-b]pyridazine derivatives corresponding to general formula (I):Wherein R2, R3, R7, R8, A, L and B are as defined herein. Also disclosed are the preparative methods and therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.